StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Reinstates Bristol-Myers Squibb Co. (BMY) at Overweight
May 3, 2019 6:45 AM
JPMorgan analyst Chris Schott reinstates coverage on Bristol-Myers Squibb Co. (NYSE: BMY) with a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
New Coverage